Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenue, net of returns, allowances and discounts $ 4,594 $ 3,957
Cost of revenues 1,660 1,590
Gross profit 2,934 2,367
Operating expenses    
Selling, general and administrative 7,740 9,740
Royalties 185 217
Research and product development 111 199
Acquisition-related 635 0
Change in fair value of contingent consideration liability 35 362
Total operating expenses 8,706 10,518
Loss from operations (5,772) (8,151)
Other (expense) income    
Interest expense (573) (619)
Interest income 2 8
Change in fair value of warrant liability 118 737
Warrant modification expense (770) 0
Total other (expense) income (1,223) 126
Loss from continuing operations before tax (6,995) (8,025)
Income tax expense (3) (3)
Loss from continuing operations (6,998) (8,028)
Discontinued operations:    
Income from discontinued operations, net of tax of $0 for the three months ended March 31, 2017 and 2016 0 346
Net loss $ (6,998) $ (7,682)
Net loss per basic and diluted common share:    
Loss from continuing operations $ (0.23) $ (0.29)
Income from discontinued operations 0 0.01
Income from discontinued operations    
Net loss per basic and diluted common share $ (0.23) $ (0.28)
Weighted average shares used in computing basic and diluted net loss per common share 30,713,415 27,293,087